Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
Form 4/A amendment. Two-tranche buy: 120,000 shares at $8.7393 on Sep 18 and 190,000 shares at $8.8599 on Sep 21. Weighted avg ~$8.81. Concentrated fund with 10%+ stake. Current $9.18 (+4.2% vs buy).
Two-day cluster buy: 20,841 shares at $13.135 on Sep 22 ($273,836) + 94,120 shares at $13.079 on Sep 23 ($1,230,646). Holds indirectly through Ventus Capital KABDC LLC. Current $13.08 (flat vs buy).
Clean round-lot purchase of 5,000 shares at exactly $100/share via the Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Trust held ~429K shares prior. Current $100.33 (+0.3% vs buy).
AIThe day in insider buying
SEC Form 4 Insider Scan — September 24, 2026
Scanned the last 24 hours of EDGAR Form 4 filings (accepted September 23–24, 2026). 3 qualifying buys (≥ $250K, transaction type P) totalling $4.74M.
Headline Filings
OFIX — Juniper Investment Company, LLC (10% Owner) bought 310,000 shares ≈ $2.73M at ~$8.81 weighted avg; now $9.18 (+4.2% since buy). Filed Sep 23 as Form 4/A (amendment). Juniper is a concentrated fund (managing members John A. Bartholdson and Alexis P. Michas) that purchased 120K shares on Sep 18 and 190K shares on Sep 21, establishing a large block in this orthopedic devices name. (filing)
KBDC — James L. Robo (Director) bought 114,961 shares ≈ $1.50M at ~$13.09 weighted avg; now $13.08 (essentially flat, −0.1% since buy). Robo purchased 20,841 shares on Sep 22 and followed with a much larger 94,120-share tranche on Sep 23 (same-day filing). Holds indirectly through Ventus Capital KABDC LLC. Cluster buy across consecutive days signals conviction in this BDC. (filing)
INBX — Jon Faiz Kayyem (Director) bought 5,000 shares ≈ $500K at exactly $100.00/share; now $100.33 (+0.3% since buy). Clean round-number purchase by a director who already held ~429K shares through a family trust. (filing)
Notes
Sector themes: Healthcare devices (OFIX) and financial services (KBDC) dominated today's qualifying filings, with biotech (INBX) rounding out the list.
Just outside the 24h window — worth knowing: GameStop CEO Ryan Cohen purchased 1,150,680 shares of GME for $26.4M (filed Sep 21, now $24.20, +5.5% from his $22.94 avg); Grab Holdings CEO Anthony Tan purchased 10,350,000 shares of GRAB for $29.9M (filed Sep 22, now $3.20, +10.9% from his $2.89 avg); Grab COO Alexander Hungate added $867K in GRAB on the same date. These were the week's marquee conviction buys — both CEOs buying in size ahead of apparent catalysts.
OFIX context: Orthofix Medical (spine and orthopedics) has been trading near multi-year lows. Juniper's two-tranche buy totaling 310K shares (~$2.73M) represents a meaningful accumulation for a focused fund with a 10%+ ownership stake.
KBDC context: Kayne Anderson BDC is a business development company; director Robo's follow-on buy on the same day as the filing (Sep 23) after a Sep 22 starter position suggests he is legging in deliberately at current levels (~$13.08 NAV-adjacent pricing).
Most-bought stocks, last 30 days
RSG$405M · 3 buys, 3 insidersRepublic Services, Inc.
MAIR$220M · 2 buys, 2 insidersMadison Air Solutions Corp
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's
stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what
average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free,
and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.